PFE Pfizer Inc. Loading...

From GILD earnings calls
Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
All directions✓
▲ Long✓
▼ Short✓
⛔ Avoid✓
✂ Close✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
21:30
Feb 10 ◎
Andrew Dickinson CFO, Gilead Sciences, Inc. GILD Q4 FY25 call
Gilead's BD strategy may target assets in competitive spaces like oncology, which includes Pfizer's offerings.
PFE
MED

About PFE Analyst Coverage

Buzzberg tracks PFE (Pfizer Inc.) across 1 sources. 0 bullish vs 0 bearish calls from 1 analysts. Sentiment: evenly split. 1 total trade idea tracked. Latest voices: Andrew Dickinson.